A detailed history of Icapital Wealth LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Icapital Wealth LLC holds 4,248 shares of GILD stock, worth $374,163. This represents 0.2% of its overall portfolio holdings.

Number of Shares
4,248
Previous 4,248 -0.0%
Holding current value
$374,163
Previous $291,000 22.34%
% of portfolio
0.2%
Previous 0.16%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 05, 2024

SELL
$73.27 - $83.09 $9,085 - $10,303
-124 Reduced 2.84%
4,248 $344,000
Q4 2021

Feb 15, 2022

BUY
$64.88 - $73.64 $283,655 - $321,954
4,372 New
4,372 $317,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Icapital Wealth LLC Portfolio

Follow Icapital Wealth LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Icapital Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Icapital Wealth LLC with notifications on news.